Skip to main content
SpringerLink
Log in

Leukodystrophy and Bone Marrow Transplantation: Role of Mixed Hematopoietic Chimerism

  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Bone Marrow Transplantation (BMT) is currently the most physiologic treatment for some types of leukodystrophies. In enzyme deficiency states, replacement of defective genes with cells carrying “normal” copies of these genes offers a natural form of gene therapy. This review will cover the various disease states which may be treated using bone marrow transplantation as well as the obstacles and advantages offered by this treatment modality. The potential for mixed hematopoietic chimerism, with reference to the advantages and disadvantages of treating various leukodystrophies, is reviewed. Finally, certain approaches which would reduce the morbidity and mortality associated with conventional BMT are discussed. If these obstacles can be overcome, BMT may offer the hope of cure to a number, but certainly not all, leukodystrophies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Thomas, E.D., Lochte, H.L., Cannon, J.H., Sahler, D.D., and Freebee, J.W. 1959. Supralethal whole body irradiation and isologous marrow transplantation in man. J. Clin. Invest. 38:1709.

    Google Scholar 

  2. Murphy, W.J., Reynolds, C.W., Tiberghien, P., and Longo, D.L. 1993. Natural killer cells and bone marrow transplantation. J. National Cancer Inst. 85:1475.

    Google Scholar 

  3. Down, J.D., Tarbell, N.J., Thames, H.D., and Mauch, P.M. 1991. Syngeneic and allogeneic bone marrow engraftment after total body irradiation: Dependence on dose, dose rate, and fractionation. Blood 77:661.

    Google Scholar 

  4. Nilsson, S., Doone, M., Tiarks, C., Weier, H., Quesenberry, P.J. 1997. Potential and distribution of transplanted hematopoietic stem cell in a nonablated mouse model. Blood 89:4013.

    Google Scholar 

  5. Down, J.D., Boudewijn, A., Dillingh, J.H., Fox, B.W., and Ploemacher, R.E. 1994. Relationships between ablation of distinct haemopoietic cell subsets and the development of donor bone marrow engraftment following recipient pretreatment with different alkylating drugs. British. J. Cancer 70:611.

    Google Scholar 

  6. Colson, Y.L., Wren, S.M., Schuchert, M.J., Patrene, K.D., Johnson, P.C., Boggs, S.S., and Ildstad, S.T. 1998. A nonlethal conditioning approach to achieve durable multilineage mixed chimerism and tolerance across major, minor, and hematopoietic histocompatibility barriers. J. Immunology 155:4179.

    Google Scholar 

  7. Exner, B.G., Colson, Y.L., Li, H., and Ildstad, S.T. 1997. In vivo depletion of host CD4+ and CD8+ cells permits engraftment of bone marrow stem cells and tolerance induction with minimal conditioning. Surgery 122:221.

    Google Scholar 

  8. Storb, R., Yu, C., Wagner, J.L., Deeg, H.J., Nash, R.A., Kiem, H.P., Leisenring W., and Shulman, H. 1997. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation. Blood 89:3048.

    Google Scholar 

  9. Ildstad, S.T., Bluestone, J.A., and Sachs, D.H. 1986. Alloresistance to engraftment of allogeneic donor bone marrow is mediated by an LyT2+ T-cell in mixed allogeneic reconstitution (C57BL 10/Sn + B 10.D2/nSn->C57BL 10/Sn). J. Exp. Med. 163:1343.

    Google Scholar 

  10. Billingham, R.E. 1966. The biology of graft-versus host disease. Harvey Lectures 62:21.

    Google Scholar 

  11. Martin, P.J., Hansen, J.A., Storb R., and Thomas, E.D. 1987. Human marrow transplantation: An immunological perspective. Advances in Immunology 40:379.

    Google Scholar 

  12. Glucksberg, H., Storb, R., Fefer, A., Buckner, C.D., Neiman, P.E., Clift, R., Lerner, K.G., and Thomas, E.D. 1974. Clinical manifestations of graft-versus host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 18:295.

    Google Scholar 

  13. Takata, M., Imai, T., and Hirone, T. 1993. Immunoelectronmicroscopy of acute graft versus host disease of the skin after allogeneic bone marrow transplantation. Journal of Clinical Pathology 46:801.

    Google Scholar 

  14. Truitt, R.L., and Atasoylu, A.A. 1991. Contribution of CD4 and CD8 T cells to graft versus host disease and graft bersus leukemia reactivity after transplantation of MHC compatible bone marrow. Bone Marrow Transplantation 8:51.

    Google Scholar 

  15. Blazar, B.R., Taylor, P.A., Panoskaltsis-Mortarim, A., Barrett, T.A., Bluestone, J.A., and Vallera, D.A. 1996. Lethal murine graft versus host disease induced by donor gamma delta expressing T cells with specificity for host non-classical major histocompatibility complex class Ib antigens. Blood 87:827.

    Google Scholar 

  16. Beatty, P.G., Kollman, C., and Howe, C.W. 1995. Unrelated-donor marrow transplants: the experience of the National Marrow Donor Program. Clinical Transplants 271:231.

    Google Scholar 

  17. Korngold, B., and Sprent, J. 1978. Lethal graft-versus host diesease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow. Journal of Experimental Medicine 148:1687.

    Google Scholar 

  18. Yeager, A.M., Vogelsang, G.B., Jones, R.J., Farmer, E.R., Hess, A.D., and Santos, G.W. 1993. Cyclosporine induced graft-versus-host disease after autologous bone marrow transplantation for acute myeloid leukemia. Leukemia & Lymphoma 11:215.

    Google Scholar 

  19. Appleton, A.L., Sviland, L., Wilkes, J., Pearson, A.D., and Malcolm, A.J. 1994. Late development of graft versus host disease in an autologous BMT recipient. Bone Marrow Transplantation 13:823.

    Google Scholar 

  20. Armitage, J.O. 1994. Bone marrow transplantation. N. Eng. J. Med. 330:827.

    Google Scholar 

  21. Hansen, J.A., Anasetti, C., and Martin, P.J. 1994. The Seattle Experience, p. 193-209 in Terasaki, P.I., Checka, J.M. (eds.), Clinical Transplants, UCLA Tissue Typing Laboratory, Los Angeles.

    Google Scholar 

  22. Beatty, P.G., Clift, R., Mickelson, E.M., Nisperos, B., Slournoy, N., Martin, P.J., Sanders, J.E., Stewart, P., Puckner, C.D., Storb, R., Thomas, E.D., and Hansen, J.A. 1985. Marrow transplantation from related donors other than HLA-identical siblings. N. Eng. J. Med. 313:765.

    Google Scholar 

  23. Anasetti, C., Amos, D., Beatty, P.G., Appelbaum, F., Bensinger, W., Buckner, C.D., Clift, R., Doney, K., Martin, P.J., Micleson, E., Nisperos, B., O'Quigley, J., Ramberg, R., Sanders, J.E., Stewart, P., Storb, R., Sullivan, K.M., Witherspoon, R., Thomas, F.D., and Hansen, J.A. 1989. Effect of HLA compatibility on engraftment of bone marrow in patients with leukemia or lymphoma. N. Eng. J. Med. 320:197.

    Google Scholar 

  24. Freytes, C.O., Beatty, P.G.: Representation of Hispanics in the National Marrow Donor Program. Bone Marrow Transplantation 17:323, 1996.

    Google Scholar 

  25. Beatty, P.G., Anasetti, C., and Hansen, J.A. 1993. Marrow transplantation from unrelated donors for treatment of hematologic malignancies: Effect of mismatching for one HLA locus. Blood 81:249.

    Google Scholar 

  26. Hansen, J.A. 1996. Development of registries of HLA-typed volunteer marrow donors. Tissue Antigens 47:460.

    Google Scholar 

  27. Hansen, J.A., Petersdorf, E., Martin, P.J., and Anasetti, C. 1997. Hematopoietic stem cell transplants from unrelated donors. Immunological Reviews 157:141.

    Google Scholar 

  28. Kernan N. 1994. T-cell depletion for prevention of graft versus host disease, p. 124, in Forman S.J., Blume K.J., Thomas, E.D. (eds.), Bone Marrow Transplantation, Blackwell Scientific Publications, Oxford.

    Google Scholar 

  29. Martin, P.J., Hansen, J.A., Torok-Storb, B., Durnam, D., Przepiorka, D., O'Quigley, J., Sanders, J., Sullivan, K.M., Witherspoon, R.P., Deeg, H.J., Appelbaum, R.R., Stewart, P., Weiden, P., Doney, K., Buckner, C.D., Clift, R., Storb, R., and Thomas, E.D. 1988. Graft failure inpatients receiving T cell-depleted HLA-identical allogeneic marrow transplants. Bone Marrow Transplant 3:445.

    Google Scholar 

  30. Marmont, A.M., Horowitz, M.M., Gale, R.P., Sobocinski, K., Ash, R.C., Van Bekkum, D.W., Champlin, R.E., Dicke, K.A., Goldman, I.M., Good, R.A., Herzig, R.H., Hong, R., Masaoka, T., Rimm, A.A., Ringden, O., Speck, B., Weiner, R.S., and Bortin, M.M. 1991. T-cell depletion of HLA-identical transplants in leukemia. Blood 78:2120.

    Google Scholar 

  31. Shizuru, J.A., Jerabek, L., Edwards, C.T., and Weismann, I.L. 1996. Transplantation of purified hematopoietic stem cells: Requirements for overcoming the barriers of allogeneic engraftment. Biology of Blood and Marrow Transplantation 2:3.

    Google Scholar 

  32. Shizuru, J.A., Jerabek, L., Edwards, C.T., and Weissman, I.L. 1996. Transplantation of purified hematopoietic stem cells: Requirements for overcoming the barriers of allogeneic engraftment. Biology of Blood and Marrow Transplantation 2:3.

    Google Scholar 

  33. Kaufman, C.L., Colson, Y.L., Wren, S.M., Watkins, S.L., Simmons, R.L., and Ildstad, S.T. 1994. Phenotypic characterization of a novel bone-marrow derived cell that facilitates engraftment of allogeneic bone marrow stem cells. Blood 84:2436.

    Google Scholar 

  34. Nilsson, S., Doone, M., Tiarks, C., Weier, H., and Quesenberry, P.J. 1997. Potential and distribution of transplanted hematopoietic stem cell in a nonablated mouse model. Blood 89:4013.

    Google Scholar 

  35. Vallera, D.A., and Blazar, B.R. 1989. T cell depletion for graft-versus-host disease prophylaxis. A perspective on engraftment in mice and humans. Transplantation 47:751.

    Google Scholar 

  36. Blazar, B.R., Filipovich, A.H., Kersey, J.H., Uckun, F.M., Ramsay, N.C., McGlave, P.B., and Vallera, D.A. 1987. T-cell depletion of donor marrow grafts: Effects on graft-versus-host disease and engraftment. New York, NY. Liss, p. 381.

    Google Scholar 

  37. Martin, P., Hansen, J., Buckner, C., Sanders, J., Deeg, H., Stewart, P., Appelbaum, F., Clift, R., Fefer, A., Witherspoon, R., Kennedy, M., Sullivan, K., Flournoy, N., Storb, R., and Thomas, E. 1985. Effects of in vitro depletion of T-cells in HLA-identical allogeneic marrow grafts. Blood 66:6641.

    Google Scholar 

  38. Storb, R., Deeg, H.J., Pepe, M., Appelbaum, F., Anasetti, C., Beatty, P., Bensinger, W., Berenson, R., Buckner, C.D., Clift, R., Doney, K., Longton, G., Hansen, J., Hill, R., Loughran, T., Jr., Martin, P., Singer, J., Sanders, J., Stewart, P., Sullivan, K., Witherspoon, R., and Thomas, E. 1989. Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: Long-term follow-up of a controlled trial. Blood 73:1729.

    Google Scholar 

  39. Dunn, W.A., Raizada, M.K., Vogt, E.S., and Brown, E.A. 1994. Growth factor-induced neurite growth in primary neuronal cultures of dogs with neuronal ceroid lipofuscinosis. Int J Dev Neurosci 12:185.

    Google Scholar 

  40. Faust J.R., Rodman J.S., Daniel P.F., Dice J.F., and Bronson R.T. 1994. Two related proteolipids and dilichol-linked oligosaccharides accumulate in motor neuron degeneration mice (mnd/mnd), a model for neuronal ceroid lipofuscinosis. J. Biol. Chem. 269:10150.

    Google Scholar 

  41. Lipman R.D., Donohue L.R., Hoppe P., and Bronson R.T. 1996. Evidence that lysosomal storage of proteolipids is a cell autonomous process in the motor neuron degeneration (mnd) mouse, a model of neuronal ceroid lipofuscinosis. Neurosci. Lett. 219:111.

    Google Scholar 

  42. Leong S.K., and Ling E.A. 1993. Origin and nature of ramified and ameboid microglia: A historical review and current concepts. Glia 6:39.

    Google Scholar 

  43. Unger E., Sung H., Manivel J.C., Cheggis M.L., Blazar B.R., and Krivit W. 1993. Male donor-derived cells i the brains of female sex-mismathced bone marrow transplant recipients: A y-chromo-some specific in-situ hybridization study. J. Neuropathaol. Exp. Neurol. 52:460.

    Google Scholar 

  44. Krivit W., Sung J.H., Shapiro E.G., Lockman L.A. 1995. Microglia: the effector cell for reconstitution of the central nervous system following bone marrow transplantation for lysosomal and peroxisomal storage diseases. [Review] [71 refs]. Cell Transplantation 4:385.

    Google Scholar 

  45. Kennedy D.W., and Abkowitz J.L. 1997. Kinetics of central nervous system microglial and macrophage engraftment: analysis using a transgenic bone marrow transplantation model. Blood 90:986.

    Google Scholar 

  46. Suzuki K. 1985. Genetic galctosylceramidase deficiency (globoid cell keukodystrophy, Krabbe disease) in different mammalian species. Neurochemical Pathology 3:53.

    Google Scholar 

  47. Suzuki K. 1995. The twitcher mouse: a model for Krabbe disease and for experimental therapies. [Review][63 refs]. Brain Pathology. 5:249.

    Google Scholar 

  48. Bradl M., and Linington C. 1996. Animal models of demyelination. [Review] [78 refs]. Brain Pathology 6:303.

    Google Scholar 

  49. Suzuki KSK. 1995. The twitcher mouse: A model for Krabbe disease and for experimental therapies. Brain Pathology 5:249.

    Google Scholar 

  50. Yeager A., Shinn C., Shinohara M., and Pardoll D. 1993. Hematopoietic cell transplantation in the twitcher mouse. Transplantation 56:185.

    Google Scholar 

  51. Neufeld E.F., and Muenzer J. 1995. The Mucopolysaccharidoses, p 2465, in Scirver CR, Beaudet AL, Sly WS, Valle D (eds.), The metabolic and molecular bases of inherited disease, McGraw-Hill, New York.

    Google Scholar 

  52. Simonaro C.M., Haskins M.E., Kunieda T., Evans S.M., Visser J.W., and Schuchman, E.H. 1997. Bone marrow transplantation in newborn rats with mucopolysaccharidosis type VI: biochemical, pathological, and clinical findings. Transplantation 63:1386.

    Google Scholar 

  53. Neufeld E.F., and Muenzer J. 1995. The Mucopolysaccharidoses, p. 2466, in Scirver CR, Beaudet AL, Sly WS, Valle D (eds.), The metabolic and molecular bases of inherited disease, McGraw-Hill, New York.

    Google Scholar 

  54. Gasper P.W., Thrall M.A., and Wenger D.A., et. al., 1984. Correction of feline arylsulfatase B deficiency (MPS VI) by bone marrow transplantation. Nature 312:467.

    Google Scholar 

  55. Wenger D.A., Gasper P.W., Thrall M.A., Dial S.M., LeCouteur R.A., and Hoover E.A. 1986. Bone marrow transplantation in the feline model of arylsulfatase B deficiency. Birth Defects 22:177.

    Google Scholar 

  56. Sands M.S., Barker J.E., Vogler C., Levy B., Gwynn B., Galvin N., Sly W.S., and Birkenmeier E. 1993. Treatment of murine mucopolysaccharidosis type VII by syngeneic BMT in neonates. J. Clin. Invest. 68:676.

    Google Scholar 

  57. Wolfe J.H., Sands M.S., Barker J.E., Gwynn B, Rowe L., Vogler C., and Birkenmeier E. 1992. Reversal of pathology in murine mucopolysaccharidosis type VII by somatic cell gene transfer. Nature 360:749.

    Google Scholar 

  58. Marchael V., Naffakh N., Danos O., and Heard J.M. 1933. Disappearance of lysosomal storage in spleen and liver of mucopolysaccharidosis VII mice after transplantation of genetically modified bone marrow stem cells. Blood 82:1358.

    Google Scholar 

  59. Sands M.S., Erway L.C., Vogler C., Sly W.S., and Birkenmeier E.H. 1995. Syngeneic bone marrow transplantation reduces the hearing loss associated with murine mucopolysaccharidosis type VII. Blood 86:2033.

    Google Scholar 

  60. Krivit W., Lockman L.A., Watkins P.A., Hirsch J., and Shapiro E.G. 1995. The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leukodystrophy and Hurler syndrome. [Review] [23 refs]. Journal of Inherited Metabolic Disease 18:398.

    Google Scholar 

  61. Walkley S.U., Thrall M.A., Dobrenis K., Huang M., March P.A., Siegel D.A., and Wurzelmann S. 1994. Bone marrow transplantation corrects the enzyme defect in neurons of the central nervous system in a lysosomal storage disease. Proceedings of the National Academy of Sciences of the United States of America 91:2970.

    Google Scholar 

  62. Vandevelde M., Fankhauser R., Bichsel P., Wiesmann U., and Herschkowitz N.: Hereditary neurovisceral mannosidosis associated with alpha-mannosidase deficiency in a family of Persian cats. Acta Neuropathologica 58:64, 1982

    Google Scholar 

  63. Cummings J.F., Wood P.A., de Lahunta A., Walkley S.U., and Le Boeuf L. 1988. The clinical and pathologic heterogeneity of feline alpha-mannnosidosis. Journal of Veterinary Internal Medicine 2:163.

    Google Scholar 

  64. Shull R.M., Hastings N.E., Selcer R.R., Jones J.B., Smith J.R., Cullen W.C., and Constantopoulos G. 1987. Bone marrow transplantation in canine mucopolysaccharidosis I. Effects within the central nervous system. Journal of Clinical Investigation 79:435.

    Google Scholar 

  65. Hoogerbrugge P.M., Brouwer O.F., Bordigoni P., Ringden O., Kapaun P., Ortega, J.J., O'Meara A., Cornu G., Souillet G., and Frappaz D. 1995. Allogeneic bone marrow transplantation for lysosomal storage diseases. The European Group for Bone Marrow Transplantation [see comments]. Lancet 345:1398.

    Google Scholar 

  66. Kidd D., Nelson J., Jone F., Dusoir H., Wallace I., McKinstry S., and Pearson-White S. 1998. Long-term stabilization after bone marrow transplantation in juvenile metachromatic leukodystrophy. Arch Neurol 55:98.

    Google Scholar 

  67. Joss V., Roger T.R., and Hugh-Jones K. 1982. A bone marrow transplant for metachromatic leukodystrophy. Exp. Hematology. 10:52.

    Google Scholar 

  68. Hoogerbrugger P.M., Brouwer O.F., and Fischer A. 1991. Bone marrow transplantation for metabolic diseases with severe neurological symptoms. Bone Marrow Transplant 7:71.

    Google Scholar 

  69. Hoogerbrugge P.M., Brouwer O.F., Bordigoni P., Ringden O., Kapaun P., Ortega, J.J., O'Meara A., Cornu G., Souillet G., and Frappaz D. 1995. Allogeneic bone marrow transplantation for lysosomal storage diseases. The European Group for Bone Marrow Transplantation [see comments]. Lancet 345:1398.

    Google Scholar 

  70. Krivit W. P. M., and Ayaz K. 1984. Bone marrow transplantation in the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI). N. Engl. J. Med. 311:1606.

    Google Scholar 

  71. Resnick M., Krivit W., and Snover D.C. 1982. Pathology in the liver in mucopolysaccharidosis: Light and electron micorscopic assessment before and after bone marrow transplantation. Bone Marrow Transplantation 10:273.

    Google Scholar 

  72. Gasper P.W., Thrall M.A., and Wenger D.A., et. al. 1984. Correction of feline arylsulfatase B deficiency (MPS VI) by bone marrow transplantation. Nature 312:467.

    Google Scholar 

  73. Norrdin R.W., Moffat K.S., Thrall M.A., and Gasper P.W. 1993. Characterization of osteopenia in feline mucopolysaccharidosis VI and evaluation of bone marrow transplantation therapy. Bone 14:361.

    Google Scholar 

  74. Wenger D.A., Gasper P.W., Thrall M.A., Dial S.M., LeCouteur R.A., and Hoover E.A. 1986. Bone marrow transplantation in the feline model of arylsulfatase B deficiency. Birth Defects 22:177.

    Google Scholar 

  75. McGovern M.M., Ludman M.D., and Short M.P., et. al. 1986. Bone marrow transplantation in Maroteaux-Lamy syndrome (MPS type 6): Status 40 months after BMT. Birth Defects 22:41.

    Google Scholar 

  76. Malm G., Ringden O., Winiarski J., Grondahl E., Uyebrant P., Eriksson U., Hakansson H., Skjeldal O., and Mansson J.E. 1996. Clinical outcome in four children with metachromatic leukodystrophy treated by bone marrow transplantation. Bone Marrow Transplantation 17:1003.

    Google Scholar 

  77. Navarro C., Dominguez C., Fernandez J.M., Fachal C., and Alvarez M. 1995. Case report: four-year follow-up of bone-marrow transplantation in late juvenile metachromatic leukodystrophy. Journal of Inherited Metabolic Disease 18:157.

    Google Scholar 

  78. Yazaki M., Ohno T., Matsubayashi T., Yamada K., Osaka Y., Yamamori K., Ishikawa T., Wada Y., and Sakuraba H. 1995. Detection of donor lymphocytes in the cerebrospinal fluid of a patient with metachromatic leukodystrophy following bone marrow transplantation. Bone Marrow Transplantation 15:137.

    Google Scholar 

  79. Nagai T., Kaneko T., Shichijou H., Karato T., Maruyama A., and Tsuchiya Y. 1993. Bone marrow transplantation for late infantile metachromatic leukodystrophy: pathogenic investigation for graft rejection. Acta Paediatrica Japonica 35:404.

    Google Scholar 

  80. Bambach B.J., Moser H.W., Blakemore K., Corson V.L., Griffin C.A., Noga S.J., Perlman E.J., Zuckerman R., Wenger D.A., and Jones R.J. 1997. Engraftment following in utero bone marrow transplantation for globoid cell leukodystrophy. Bone Marrow Transplantation 19:399.

    Google Scholar 

  81. Staba M.J., Goldman S., Johnson F.L., and Huttenlocher P.R. 1997. Allogeneic bone marrow transplantation for Alexander's disease. Bone Marrow Transplantation 20:247.

    Google Scholar 

  82. Di Francesco C., Cracco C., Tomain R., Picci L., Ventura L., Zacchello E., Di Natale P., Anson D.S., and Howood J.J. 1997. In vitro correction of iduronate-2-sulfatase deficiency by adenovirus-mediated transfer. Gene. Therapy 4:442.

    Google Scholar 

  83. Krivit W., Shapiro E.G., Peters C.P., Wagner J.E., Cornu G., Kurtzberg J., Wenger D.A., Kolodny E.G., Vanier M.T., Loes D.J., Dusenbery K., and Lockman L.A. 1998. Hematopoietic stem-cell transplantation in globoid-cell leukodystrophy. N. Eng. J. Med. 330:1119.

    Google Scholar 

  84. Hoogerbrugge P.M., Brouwer O.F., Bordigoni P., Ringden O., Kapaun P., Ortega, J.J., O'Meara A., Cornu G., Souillet G., and Frappaz D. 1995. Allogeneic bone marrow transplantation for lysosomal storage diseases. The European Group for Bone Marrow Transplantation [see comments]. Lancet 345:1398.

    Google Scholar 

  85. Suzuki K., and Taniike M. 1995. Murine model of genetic demyelinating disease: the twitcher mouse. [Review] [61 refs]. Microscopy Research & Technique 32:204.

    Google Scholar 

  86. Vassal G., Fischer A., Challine D., Boland I., Ledheist F., Lemerie S., Vilmer E., Rahimy C., Souillet G., Gluckman E., Michel G., Deroussent A., and Gouyette A. 1993. Busulfan disposition below the age of three: Alteration in children with lysosomal storage disease. Blood 82:1030.

    Google Scholar 

  87. Vassal G., Deroussent A., Challien D., Harment O., Koscielny S., Valteau-Couanet D., Lemerle J., and Gouyette A. 1992. Is 600 mg/kg2 the appropriate dosage of busulfan in children undergoing bone marrow transplantation? Blood 79:2475.

    Google Scholar 

  88. Grochow L.B., Piantadosi S., Santos G., and Jones R. 1992. Busulfan doses adjustment decreases the risk of veno-occulsive disease in patients undergoing bone marrow transplantation. Proc. American Assoc. Cancer Res. 33:200.

    Google Scholar 

  89. Nash R.A., Seidel K., Storb R., Slichter S., Schuening F.G., Appelbaum F.R., Becker A.B., Bolles L., Deeg H.J., and Graham T. 1995. Effects of rhIL-11 on normal dogs and after sublethal radiation. Experimental Hematology 23:389.

    Google Scholar 

  90. Cobbold S.P., Martin G., Qin S., and Waldmann H. 1986. Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance. Nature 323:164.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute for Cellular Therapeutics., USA

    Christina L. Kaufman (Ph.D.) & Suzanne T. Ildstad

  2. University of Louisville, School of Medicine, Louisville, KY, 40292

    Christina L. Kaufman (Ph.D.)

Authors
  1. Christina L. Kaufman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Suzanne T. Ildstad
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaufman, C.L., Ildstad, S.T. Leukodystrophy and Bone Marrow Transplantation: Role of Mixed Hematopoietic Chimerism. Neurochem Res 24, 537–549 (1999). https://doi.org/10.1023/A:1022587914079

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1022587914079

Search

Navigation